Baldwin Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $778K | Sell |
1,552
-17
| -1% | -$8.16K | 0.05% | 123 |
|
|
2026
Q1 | $771K | Sell |
1,569
-813
| -34% | -$441K | 0.06% | 118 |
|
|
2025
Q4 | $1.38M | Hold |
2,382
| – | – | 0.09% | 99 |
|
|
2025
Q3 | $1.16M | Sell |
2,382
-210
| -8% | -$97.7K | 0.08% | 104 |
|
|
2025
Q2 | $1.05M | Sell |
2,592
-2,898
| -53% | -$1.21M | 0.07% | 99 |
|
|
2025
Q1 | $2.73M | Sell |
5,490
-132
| -2% | -$71.5K | 0.19% | 76 |
|
|
2024
Q4 | $2.92M | Sell |
5,622
-103
| -2% | -$56.6K | 0.2% | 74 |
|
|
2024
Q3 | $3.54M | Sell |
5,725
-33
| -0.6% | -$19.5K | 0.24% | 69 |
|
|
2024
Q2 | $3.18M | Sell |
5,758
-256
| -4% | -$147K | 0.25% | 67 |
|
|
2024
Q1 | $3.5M | Sell |
6,014
-1,271
| -17% | -$713K | 0.26% | 68 |
|
|
2023
Q4 | $3.87M | Sell |
7,285
-626
| -8% | -$303K | 0.3% | 65 |
|
|
2023
Q3 | $4M | Sell |
7,911
-309
| -4% | -$165K | 0.34% | 64 |
|
|
2023
Q2 | $4.29M | Sell |
8,220
-85
| -1% | -$45.9K | 0.35% | 62 |
|
|
2023
Q1 | $4.79M | Sell |
8,305
-18
| -0.2% | -$10.1K | 0.42% | 59 |
|
|
2022
Q4 | $4.58M | Buy |
8,323
+4,095
| +97% | +$2.17M | 0.42% | 64 |
|
|
2022
Q3 | $2.14M | Sell |
4,228
-27
| -0.6% | -$15.1K | 0.3% | 50 |
|
|
2022
Q2 | $2.31M | Sell |
4,255
-28
| -0.7% | -$15.4K | 0.3% | 49 |
|
|
2022
Q1 | $2.53M | Buy |
4,283
+287
| +7% | +$165K | 0.27% | 54 |
|
|
2021
Q4 | $2.67M | Hold |
3,996
| – | – | 0.27% | 53 |
|
|
2021
Q3 | $2.28M | Hold |
3,996
| – | – | 0.25% | 54 |
|
|
2021
Q2 | $2.02M | Sell |
3,996
-22
| -0.5% | -$10.4K | 0.22% | 58 |
|
|
2021
Q1 | $1.83M | Sell |
4,018
-297
| -7% | -$142K | 0.22% | 61 |
|
|
2020
Q4 | $2.01M | Sell |
4,315
-106
| -2% | -$49.7K | 0.25% | 56 |
|
|
2020
Q3 | $1.95M | Hold |
4,421
| – | – | 0.27% | 58 |
|
|
2020
Q2 | $1.6M | Sell |
4,421
-35
| -0.8% | -$11.7K | 0.24% | 63 |
|
|
2020
Q1 | $1.26M | Sell |
4,456
-40
| -0.9% | -$12.6K | 0.22% | 67 |
|
|
2019
Q4 | $1.46M | Buy |
4,496
+38
| +0.9% | +$11.5K | 0.2% | 70 |
|
|
2019
Q3 | $1.3M | Sell |
4,458
-2,863
| -39% | -$820K | 0.2% | 70 |
|
|
2019
Q2 | $2.15M | Sell |
7,321
-768
| -9% | -$212K | 0.32% | 59 |
|
|
2019
Q1 | $2.21M | Hold |
8,089
| – | – | 0.33% | 58 |
|
|
2018
Q4 | $1.81M | Hold |
8,089
| – | – | 0.3% | 58 |
|
|
2018
Q3 | $1.98M | Buy |
8,089
+1,391
| +21% | +$320K | 0.28% | 61 |
|
|
2018
Q2 | $1.39M | Hold |
6,698
| – | – | 0.22% | 71 |
|
|
2018
Q1 | $1.38M | Sell |
6,698
-347
| -5% | -$72.8K | 0.22% | 68 |
|
|
2017
Q4 | $1.34M | Buy |
7,045
+95
| +1% | +$18.2K | 0.21% | 77 |
|
|
2017
Q3 | $1.31M | Hold |
6,950
| – | – | 0.21% | 76 |
|
|
2017
Q2 | $1.21M | Sell |
6,950
-2,400
| -26% | -$403K | 0.2% | 77 |
|
|
2017
Q1 | $1.44M | Sell |
9,350
-77,714
| -89% | -$11.9M | 0.24% | 68 |
|
|
2016
Q4 | $12.3M | Sell |
87,064
-1,642
| -2% | -$242K | 2.22% | 12 |
|
|
2016
Q3 | $14.1M | Sell |
88,706
-17,124
| -16% | -$2.64M | 2.56% | 8 |
|
|
2016
Q2 | $15.6M | Buy |
105,830
+1,220
| +1% | +$180K | 3.22% | 6 |
|
|
2016
Q1 | $14.8M | Buy |
104,610
+8,130
| +8% | +$1.09M | 2.66% | 6 |
|
|
2015
Q4 | $13.7M | Sell |
96,480
-4,048
| -4% | -$540K | 2.23% | 6 |
|
|
2015
Q3 | $12.3M | Buy |
100,528
+45,561
| +83% | +$5.94M | 2.07% | 7 |
|
|
2015
Q2 | $7.13M | Buy |
54,967
+35,802
| +187% | +$4.67M | 1.06% | 31 |
|
|
2015
Q1 | $2.58M | Sell |
19,165
-425
| -2% | -$54.8K | 0.38% | 66 |
|
|
2014
Q4 | $2.45M | Sell |
19,590
-4,353
| -18% | -$529K | 0.35% | 67 |
|
|
2014
Q3 | $2.91M | Buy |
23,943
+2,978
| +14% | +$362K | 0.41% | 61 |
|
|
2014
Q2 | $2.47M | Buy |
20,965
+5,807
| +38% | +$683K | 0.37% | 66 |
|
|
2014
Q1 | $1.82M | Buy |
15,158
+4,401
| +41% | +$523K | 0.29% | 69 |
|
|
2013
Q4 | $1.2M | Buy |
10,757
+4,735
| +79% | +$471K | 0.19% | 111 |
|
|
2013
Q3 | $555K | Buy |
6,022
+157
| +3% | +$14.2K | 0.1% | 156 |
|
|
2013
Q2 | $496K | Buy |
+5,865
| New | +$488K | 0.1% | 148 |
|
Other funds holding TMO
RG
ECSS
LT
Baldwin Wealth Partners's TMO Position: Q2 2026 in Review
Baldwin Wealth Partners reduced its Thermo Fisher Scientific (TMO) stake by 1.1% in Q2 2026, selling an estimated $8.16K and leaving 1,552 shares worth $778K. The position accounts for 0.05% of the portfolio, ranked #123.
Baldwin Wealth Partners first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.6M in Q2 2016. 1,104 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Baldwin Wealth Partners held 1,552 shares of Thermo Fisher Scientific worth $778K as of Q2 2026.
- Baldwin Wealth Partners sold 17 Thermo Fisher Scientific shares in Q2 2026, an estimated $8.16K.
- Thermo Fisher Scientific made up 0.05% of Baldwin Wealth Partners's portfolio in Q2 2026, its #123 holding.
- Baldwin Wealth Partners first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Baldwin Wealth Partners's Thermo Fisher Scientific position peaked at $15.6M in Q2 2016.
- 1,104 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Baldwin Wealth Partners's 13F filing for Q2 2026, filed 14 Jul 2026.